Cologne, Germany

Lena Schaffert

This inventor holds 1 USPTO granted patent and 2 published patent applications. Top assignee: Universitat Bielefeld. Active years: 2025.

USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:


Years Active: 2025

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations of Lena Schaffert in Acarbose Formation

Introduction

Lena Schaffert is an accomplished inventor based in Cologne, Germany. She has made significant contributions to the field of biotechnology, particularly in the formation of acarbose. Her innovative work has led to advancements that could impact various applications in medicine and agriculture.

Latest Patents

Lena Schaffert holds a patent titled "Methods for the improved formation of acarbose." This invention relates to Actinomycetales strains engineered to enhance the production of acarbose. The patent details strains that overexpress dTDP-D-glucose-4,6-dehydratase (AcbB) and/or uridyltransferase (GtaB). Additionally, it includes strains with reduced or absent expression of the small carbohydrate binding protein (Cgt) and genes essential for carotenoid synthesis. The patent also provides tools, methods, and means to generate these engineered strains.

Career Highlights

Lena Schaffert is affiliated with Universitat Bielefeld, where she continues her research and development in biotechnology. Her work has garnered attention for its potential applications in improving the efficiency of acarbose production.

Collaborations

Lena has collaborated with notable colleagues such as Marcus Persicke and Jörn Kalinowski. Their combined expertise has contributed to the success of her research initiatives.

Conclusion

Lena Schaffert's innovative work in the formation of acarbose showcases her dedication to advancing biotechnology. Her contributions are paving the way for future developments in this important field.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…